The Scientist

» pharmaceuticals and developmental biology

Most Recent

image: Pfizer and Allergan to Merge

Pfizer and Allergan to Merge

By | November 23, 2015

The two drugmakers will join forces in a $160 billion deal—if it’s given the regulatory green light.

0 Comments

image: Blood Cell Development Reimagined

Blood Cell Development Reimagined

By | November 9, 2015

A new study is rewriting 50 years of biological dogma by suggesting that mature blood cells develop much more rapidly from stem cells than previously thought.

0 Comments

image: Adding Padding

Adding Padding

By | November 1, 2015

Adipogenesis in mice has alternating genetic requirements throughout the animals’ lives.

0 Comments

image: Daraprim Alternative

Daraprim Alternative

By | October 22, 2015

A specialty pharmaceuticals company announces plans to produce a toxoplasmosis drug containing the same active ingredient as the pill at the center of an ongoing drug-pricing controversy.

1 Comment

image: Stem Cell Therapy In Utero

Stem Cell Therapy In Utero

By | October 13, 2015

An upcoming clinical trial aims to correct for a disease of fragile bones in affected babies before they are born.

0 Comments

image: Teva Buys Mexican Pharma Firm

Teva Buys Mexican Pharma Firm

By | October 5, 2015

The Israeli drugmaker is purchasing the pharmaceutical company Rimsa for $2.3 billion.

0 Comments

image: Gut Bacteria Linked to Asthma Risk

Gut Bacteria Linked to Asthma Risk

By | October 1, 2015

Four types of gut bacteria found in babies’ stool may help researchers predict the future development of asthma.

0 Comments

image: Sex on the Brain

Sex on the Brain

By | October 1, 2015

Masculinization of the developing rodent brain leads to significant structural differences between the two sexes.

1 Comment

image: Sex Differences in the Brain

Sex Differences in the Brain

By | October 1, 2015

How male and female brains diverge is a hotly debated topic, but the study of model organisms points to differences that cannot be ignored.

27 Comments

image: Biotech Stocks Take a Hit

Biotech Stocks Take a Hit

By | September 30, 2015

Some say the biotech bubble has burst over concerns that drug prices are too high—and may soon be regulated.

1 Comment

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech